KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $105,777 | -99.9% | 31,111 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $116,977,000 | +3.5% | 31,111 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $113,072,000 | +115279.6% | 27,646 | +31.7% | 0.00% | +100.0% |
| Q4 2017 | $98,000 | -76.7% | 20,994 | -64.5% | 0.00% | -66.7% |
| Q3 2017 | $420,000 | -1.4% | 59,149 | +0.5% | 0.00% | 0.0% |
| Q2 2017 | $426,000 | +39.2% | 58,863 | +18.6% | 0.00% | +50.0% |
| Q1 2017 | $306,000 | -18.4% | 49,633 | -22.5% | 0.00% | -33.3% |
| Q4 2016 | $375,000 | +17.6% | 64,077 | +6.6% | 0.00% | +50.0% |
| Q3 2016 | $319,000 | -35.8% | 60,083 | -20.0% | 0.00% | -50.0% |
| Q2 2016 | $497,000 | +41.6% | 75,108 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $351,000 | -6.4% | 75,108 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $375,000 | +43.7% | 74,234 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $261,000 | -65.2% | 74,234 | -1.1% | 0.00% | -60.0% |
| Q2 2015 | $749,000 | -25.4% | 75,052 | -4.9% | 0.01% | -28.6% |
| Q1 2015 | $1,004,000 | -1.9% | 78,887 | +9.1% | 0.01% | 0.0% |
| Q4 2014 | $1,023,000 | +2.9% | 72,299 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $994,000 | -10.6% | 72,299 | 0.0% | 0.01% | -12.5% |
| Q2 2014 | $1,112,000 | -9.7% | 72,299 | 0.0% | 0.01% | -11.1% |
| Q1 2014 | $1,232,000 | +44.8% | 72,299 | +10.1% | 0.01% | +50.0% |
| Q4 2013 | $851,000 | +28.4% | 65,687 | 0.0% | 0.01% | +20.0% |
| Q3 2013 | $663,000 | +35.0% | 65,687 | 0.0% | 0.01% | +25.0% |
| Q2 2013 | $491,000 | – | 65,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |